submitted on 2023-03-15, 08:01 and posted on 2023-03-16, 06:19authored byZohaib Yousaf, Nadeen Albaz, Alaaedin A. Abdelmajid, Taher Sabobeh, Abdel‐Naser Elzouki
<p dir="ltr">Reactivation of cytomegalovirus (CMV) in immunocompetent patients may lead to increase morbidity and mortality. A clinical suspicion allows timely diagnosis, treatment, and favorable outcome. In a subject without apparent risk factors for acute myocardial infarction (AMI), CMV can be a possibility.</p><h2>Other Information</h2><p dir="ltr">Published in: Clinical Case Reports<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="http://dx.doi.org/10.1002/ccr3.3914" target="_blank">http://dx.doi.org/10.1002/ccr3.3914</a></p>
Funding
Open Access funding provided by the Qatar National Library.